AVIR · NASDAQ
Atea Pharmaceuticals (AVIR) Stock Price & Fundamentals
Atea Pharmaceuticals (AVIR) closed at $331.46 on Oct 9, 2026, down 0.16% from the previous close of $332.00.
Share price, past year
1Y +31.58%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $331.46 |
| Sep 30, 2026 | $332.58 |
| Aug 31, 2026 | $316.76 |
| Jul 31, 2026 | $331.01 |
| Jun 30, 2026 | $319.70 |
| May 29, 2026 | $283.57 |
| Apr 30, 2026 | $274.72 |
| Mar 31, 2026 | $267.79 |
| Feb 27, 2026 | $266.10 |
| Jan 30, 2026 | $273.28 |
| Dec 31, 2025 | $263.40 |
| Nov 28, 2025 | $265.69 |
| Oct 31, 2025 | $254.90 |
Key statistics
- Market cap
- $26.58B
- P/E (TTM)
- —
- EPS (TTM)
- −$2.08
- Revenue (TTM)
- —
- Net income (TTM)
- −$165.29M
- Shares outstanding
- 80.2M
- Dividend yield
- —
- 52-week range
- $248.11 – $340.08
Atea Pharmaceuticals's market cap is $26.58B, based on a share price of $331.46 and 80.2M shares outstanding as of Jun 30, 2026.
Financials
Atea Pharmaceuticals reported revenue of $351.37M for fiscal 2021, up 622.49% from fiscal 2020.
Atea Pharmaceuticals reported a net loss of $158.35M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2021ended Dec 31, 2021 | $351.37M | +622.5% | $121.19M | 34.5% | $1.37 | −$87.01M |
| FY2020ended Dec 31, 2020 | $48.63M | — | −$10.95M | −22.5% | −$0.51 | $296.71M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2021ended Dec 31, 2021 | $192.18M | — | — |
| Q3 FY2021ended Sep 30, 2021 | $32.81M | — | — |
| Q2 FY2021ended Jun 30, 2021 | $60.39M | — | — |
| Q1 FY2021ended Mar 31, 2021 | $65.99M | — | — |
Company profile
- Name
- Atea Pharmaceuticals, Inc.
- Ticker
- AVIR
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 225 Franklin Street, Suite 2100, Boston, MA 02110
- Incorporated in
- MA
- Fiscal year ends
- December
- SEC CIK
- 0001593899
Recent SEC filings
- Aug 12, 2026
- Aug 12, 2026
- Jun 22, 2026
- May 12, 2026
- May 12, 2026
- Mar 5, 2026
- Mar 5, 2026
- Jan 8, 2026
Frequently asked questions
What is Atea Pharmaceuticals's stock price?
Atea Pharmaceuticals (AVIR) closed at $331.46 on Oct 9, 2026, down 0.16% from the previous close of $332.00.
What is Atea Pharmaceuticals's market cap?
Atea Pharmaceuticals's market cap is $26.58B, based on a share price of $331.46 and 80.2M shares outstanding as of Jun 30, 2026.
How much revenue does Atea Pharmaceuticals make?
Atea Pharmaceuticals reported revenue of $351.37M for fiscal 2021, up 622.49% from fiscal 2020.
Does Atea Pharmaceuticals pay a dividend?
Atea Pharmaceuticals's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Atea Pharmaceuticals, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures